|
Fosamax belongs to a class of drugs known as bisphosphonates. These drugs
are prescribed for treatment of osteoporosis.
Several groups of researchers have linked Fosamax, and other bisphophonates, with osteonecrosis
of the jaw. One review of 63 osteonecrosis patients found that all 63 had used bisphosphonates prior
to developing this disease.
An article published by researchers at the School of Dental Medicine at Harvard concluded that Fosamax
and other drugs in its class could cause serious complications and use of them should be carefully
monitored.
|